Selected research
Market Structure
Global Duck Virus Enteritis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Duck Virus Enteritis Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Duck Virus Enteritis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Duck Virus Enteritis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Duck Virus Enteritis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Duck Virus Enteritis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Duck Virus Enteritis Vaccine include Veterinary Research Institute, Ringpu (Tianjin)Bio-Pharmacy, Chengdu TECBOND Biological, MSD Animal Health (Merck), International Duck Research Cooperative, Institute of Veterinary Preventive Medicine, Institute of Animal Health and Veterinary Biologicals and Ceva Santé Animale, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Duck Virus Enteritis Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Duck Virus Enteritis Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Duck Virus Enteritis Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Duck Virus Enteritis Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.
Duck Virus Enteritis Vaccine Segment by Company
Veterinary Research Institute
Ringpu (Tianjin)Bio-Pharmacy
Chengdu TECBOND Biological
MSD Animal Health (Merck)
International Duck Research Cooperative
Institute of Veterinary Preventive Medicine
Institute of Animal Health and Veterinary Biologicals
Ceva Santé Animale
Duck Virus Enteritis Vaccine Segment by Type
Live Vaccines
Killed Vaccines
Duck Virus Enteritis Vaccine Segment by Application
Duck
Others
Duck Virus Enteritis Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Duck Virus Enteritis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Duck Virus Enteritis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Duck Virus Enteritis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Duck Virus Enteritis Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Duck Virus Enteritis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Duck Virus Enteritis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Duck Virus Enteritis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Live Vaccines
- Killed Vaccines
Applications
- Duck
- Others
Companies covered
- Veterinary Research Institute
- Ringpu (Tianjin)Bio-Pharmacy
- Chengdu TECBOND Biological
- MSD Animal Health (Merck)
- International Duck Research Cooperative
- Institute of Veterinary Preventive Medicine
- Institute of Animal Health and Veterinary Biologicals
- Ceva Santé Animale
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Duck Virus Enteritis Vaccine Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Duck Virus Enteritis Vaccine Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Duck Virus Enteritis Vaccine Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Duck Virus Enteritis Vaccine Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Duck Virus Enteritis Vaccine Market Dynamics
- 2.1 Duck Virus Enteritis Vaccine Industry Trends
- 2.2 Duck Virus Enteritis Vaccine Industry Drivers
- 2.3 Duck Virus Enteritis Vaccine Industry Opportunities and Challenges
- 2.4 Duck Virus Enteritis Vaccine Industry Restraints
3 Duck Virus Enteritis Vaccine Market by Manufacturers
- 3.1 Global Duck Virus Enteritis Vaccine Revenue by Manufacturers (2021-2026)
- 3.2 Global Duck Virus Enteritis Vaccine Sales by Manufacturers (2021-2026)
- 3.3 Global Duck Virus Enteritis Vaccine Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Duck Virus Enteritis Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Duck Virus Enteritis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Duck Virus Enteritis Vaccine Manufacturers, Product Type & Application
- 3.7 Global Duck Virus Enteritis Vaccine Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Duck Virus Enteritis Vaccine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Duck Virus Enteritis Vaccine Players Market Share by Revenue in 2025
- 3.8.3 2025 Duck Virus Enteritis Vaccine Tier 1, Tier 2, and Tier 3
4 Duck Virus Enteritis Vaccine Market by Type
- 4.1 Duck Virus Enteritis Vaccine Type Introduction
- 4.1.1 Live Vaccines
- 4.1.2 Killed Vaccines
- 4.2 Global Duck Virus Enteritis Vaccine Sales by Type
- 4.2.1 Global Duck Virus Enteritis Vaccine Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Duck Virus Enteritis Vaccine Sales by Type (2021-2032)
- 4.2.3 Global Duck Virus Enteritis Vaccine Sales Market Share by Type (2021-2032)
- 4.3 Global Duck Virus Enteritis Vaccine Revenue by Type
- 4.3.1 Global Duck Virus Enteritis Vaccine Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Duck Virus Enteritis Vaccine Revenue by Type (2021-2032)
- 4.3.3 Global Duck Virus Enteritis Vaccine Revenue Market Share by Type (2021-2032)
5 Duck Virus Enteritis Vaccine Market by Application
- 5.1 Duck Virus Enteritis Vaccine Application Introduction
- 5.1.1 Duck
- 5.1.2 Others
- 5.2 Global Duck Virus Enteritis Vaccine Sales by Application
- 5.2.1 Global Duck Virus Enteritis Vaccine Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Duck Virus Enteritis Vaccine Sales by Application (2021-2032)
- 5.2.3 Global Duck Virus Enteritis Vaccine Sales Market Share by Application (2021-2032)
- 5.3 Global Duck Virus Enteritis Vaccine Revenue by Application
- 5.3.1 Global Duck Virus Enteritis Vaccine Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Duck Virus Enteritis Vaccine Revenue by Application (2021-2032)
- 5.3.3 Global Duck Virus Enteritis Vaccine Revenue Market Share by Application (2021-2032)
6 Global Duck Virus Enteritis Vaccine Sales by Region
- 6.1 Global Duck Virus Enteritis Vaccine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Duck Virus Enteritis Vaccine Sales by Region (2021-2032)
- 6.2.1 Global Duck Virus Enteritis Vaccine Sales by Region (2021-2026)
- 6.2.2 Global Duck Virus Enteritis Vaccine Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Duck Virus Enteritis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Duck Virus Enteritis Vaccine Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Duck Virus Enteritis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Duck Virus Enteritis Vaccine Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Duck Virus Enteritis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Duck Virus Enteritis Vaccine Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Duck Virus Enteritis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Duck Virus Enteritis Vaccine Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Duck Virus Enteritis Vaccine Revenue by Region
- 7.1 Global Duck Virus Enteritis Vaccine Revenue by Region
- 7.1.1 Global Duck Virus Enteritis Vaccine Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Duck Virus Enteritis Vaccine Revenue by Region (2021-2026)
- 7.1.3 Global Duck Virus Enteritis Vaccine Revenue by Region (2027-2032)
- 7.1.4 Global Duck Virus Enteritis Vaccine Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Duck Virus Enteritis Vaccine Revenue (2021-2032)
- 7.2.2 North America Duck Virus Enteritis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Duck Virus Enteritis Vaccine Revenue (2021-2032)
- 7.3.2 Europe Duck Virus Enteritis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Duck Virus Enteritis Vaccine Revenue (2021-2032)
- 7.4.2 Asia-Pacific Duck Virus Enteritis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Duck Virus Enteritis Vaccine Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Duck Virus Enteritis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Veterinary Research Institute
- 8.1.1 Veterinary Research Institute Company Information
- 8.1.2 Veterinary Research Institute Business Overview
- 8.1.3 Veterinary Research Institute Duck Virus Enteritis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Veterinary Research Institute Duck Virus Enteritis Vaccine Product Portfolio
- 8.1.5 Veterinary Research Institute Recent Developments
- 8.2 Ringpu (Tianjin)Bio-Pharmacy
- 8.2.1 Ringpu (Tianjin)Bio-Pharmacy Company Information
- 8.2.2 Ringpu (Tianjin)Bio-Pharmacy Business Overview
- 8.2.3 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Product Portfolio
- 8.2.5 Ringpu (Tianjin)Bio-Pharmacy Recent Developments
- 8.3 Chengdu TECBOND Biological
- 8.3.1 Chengdu TECBOND Biological Company Information
- 8.3.2 Chengdu TECBOND Biological Business Overview
- 8.3.3 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Product Portfolio
- 8.3.5 Chengdu TECBOND Biological Recent Developments
- 8.4 MSD Animal Health (Merck)
- 8.4.1 MSD Animal Health (Merck) Company Information
- 8.4.2 MSD Animal Health (Merck) Business Overview
- 8.4.3 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Product Portfolio
- 8.4.5 MSD Animal Health (Merck) Recent Developments
- 8.5 International Duck Research Cooperative
- 8.5.1 International Duck Research Cooperative Company Information
- 8.5.2 International Duck Research Cooperative Business Overview
- 8.5.3 International Duck Research Cooperative Duck Virus Enteritis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 International Duck Research Cooperative Duck Virus Enteritis Vaccine Product Portfolio
- 8.5.5 International Duck Research Cooperative Recent Developments
- 8.6 Institute of Veterinary Preventive Medicine
- 8.6.1 Institute of Veterinary Preventive Medicine Company Information
- 8.6.2 Institute of Veterinary Preventive Medicine Business Overview
- 8.6.3 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Product Portfolio
- 8.6.5 Institute of Veterinary Preventive Medicine Recent Developments
- 8.7 Institute of Animal Health and Veterinary Biologicals
- 8.7.1 Institute of Animal Health and Veterinary Biologicals Company Information
- 8.7.2 Institute of Animal Health and Veterinary Biologicals Business Overview
- 8.7.3 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Product Portfolio
- 8.7.5 Institute of Animal Health and Veterinary Biologicals Recent Developments
- 8.8 Ceva Santé Animale
- 8.8.1 Ceva Santé Animale Company Information
- 8.8.2 Ceva Santé Animale Business Overview
- 8.8.3 Ceva Santé Animale Duck Virus Enteritis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Ceva Santé Animale Duck Virus Enteritis Vaccine Product Portfolio
- 8.8.5 Ceva Santé Animale Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Duck Virus Enteritis Vaccine Value Chain Analysis
- 9.1.1 Duck Virus Enteritis Vaccine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Duck Virus Enteritis Vaccine Production Mode & Process
- 9.2 Duck Virus Enteritis Vaccine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Duck Virus Enteritis Vaccine Distributors
- 9.2.3 Duck Virus Enteritis Vaccine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst